Christina Curtis, PhD, MSc is an Endowed Professor in the Departments of Medicine and Genetics at Stanford University where she leads the Cancer Computational and Systems Biology group. Dr. Curtis also serves as the Director of Breast Cancer Translational Research and Co-Director of the Molecular Tumor Board at the Stanford Cancer Institute. Dr. Curtis’ laboratory leverages computational modeling, high-throughput molecular profiling and experimentation to develop new ways to prevent, diagnose and treat cancer. Her research has redefined the molecular map of breast cancer, resulting in novel biomarkers that are being translated to the clinic. Additionally, she developed new paradigms in understanding how human tumors evolve and metastasize. Dr. Curtis’ research has been recognized by numerous awards, including from the V Foundation for Cancer Research, STOP Cancer and the American Association for Cancer Research (AACR). She received the National Institutes of Health Director's Pioneer Award in 2018 and the AACR Award for Outstanding Achievement in Basic Science in 2022. She is a Kavli Fellow of the National Academy of Sciences, a Susan G. Komen Scholar and a Chan Zuckerberg Biohub Investigator. Dr. Curtis is the principal investigator of over 20 awards, including three National Institutes of Health/National Cancer Institute Center grants and a Department of Defense supported clinical trial. She serves as a scientific advisor to multiple academic institutes and biotech and is a member of the AACR Board of Directors, as well as an editor for journals spanning computational biology to precision oncology.